IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishAim. Lactulose/mannitol ratio is used to assess intestinal barrier function. Aim of this work was to develop a robust and rapid method for the analysis of lactulose and mannitol in urine by liquid chromatography coupled to tandem mass spectrometry. Lactulose/mannitol ratio has been measured in pediatric patients suffering from irritable bowel syndrome. Methods. Calibration curves and raffinose, used as internal standard, were prepared in water : acetonitrile 20:80. Fifty mu L of urine sample was added to 450 mu L of internal standard solution. The chromatographic separation was performed using a Luna NH2 column operating at a flow rate of 200 mu L/min and eluted with a linear gradient from 20% to 80% water in acetonitrile. Total run time is 9 minutes. The mass spectrometry operates in electrospray negative mode. Method was fully validated according to European Medicine Agency guidelines. Results and Conclusions. Linearity ranged from 10 to 1000 mg/L for mannitol and 2.5 to 1000 mg/L for lactulose. Imprecision in intra-and interassay was lower than 15% for both analytes. Accuracy was higher than 85%. Lactulose/mannitol ratio in pediatric patients is significantly higher than that measured in controls. The presented method, rapid and sensitive, is suitable in a clinical laboratory.
Gervasoni, J., Schiattarella, A., Giorgio, V., Primiano, A., Russo, C., Tesori, V., Scaldaferri, F., Urbani, A., Zuppi, C., Persichilli, S., Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome, <<DISEASE MARKERS>>, 2016; 2016 (N/A): 1-6. [doi:10.1155/2016/5340386] [http://hdl.handle.net/10807/94400]
| Autori: | ||
| Titolo: | Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1155/2016/5340386 | |
| Data di pubblicazione: | 2016 | |
| Abstract: | Aim. Lactulose/mannitol ratio is used to assess intestinal barrier function. Aim of this work was to develop a robust and rapid method for the analysis of lactulose and mannitol in urine by liquid chromatography coupled to tandem mass spectrometry. Lactulose/mannitol ratio has been measured in pediatric patients suffering from irritable bowel syndrome. Methods. Calibration curves and raffinose, used as internal standard, were prepared in water : acetonitrile 20:80. Fifty mu L of urine sample was added to 450 mu L of internal standard solution. The chromatographic separation was performed using a Luna NH2 column operating at a flow rate of 200 mu L/min and eluted with a linear gradient from 20% to 80% water in acetonitrile. Total run time is 9 minutes. The mass spectrometry operates in electrospray negative mode. Method was fully validated according to European Medicine Agency guidelines. Results and Conclusions. Linearity ranged from 10 to 1000 mg/L for mannitol and 2.5 to 1000 mg/L for lactulose. Imprecision in intra-and interassay was lower than 15% for both analytes. Accuracy was higher than 85%. Lactulose/mannitol ratio in pediatric patients is significantly higher than that measured in controls. The presented method, rapid and sensitive, is suitable in a clinical laboratory. | |
| Lingua: | Inglese | |
| Rivista: | ||
| Citazione: | Gervasoni, J., Schiattarella, A., Giorgio, V., Primiano, A., Russo, C., Tesori, V., Scaldaferri, F., Urbani, A., Zuppi, C., Persichilli, S., Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome, <<DISEASE MARKERS>>, 2016; 2016 (N/A): 1-6. [doi:10.1155/2016/5340386] [http://hdl.handle.net/10807/94400] | |
| Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
http://hdl.handle.net/10807/94400
Copyright © 2021